Table of Contents Table of Contents
Previous Page  147 / 1082 Next Page
Information
Show Menu
Previous Page 147 / 1082 Next Page
Page Background

S134

ESTRO 36 2017

_______________________________________________________________________________________________

plan for delivery. Gamma pass-rate and mean Gamma

(

γ

mean

) were evaluated for 380 daily adaptive fractions for

over 5 months. The independent MC dose engine was

verified for site specific class solutions (Pancreas, Liver,

Lung and Prostate) using film dosimetry before clinical

implementation.

Results

Online patient specific QA for daily plan adaptation,

including 3D MC dose calculation, gamma evaluation and

automatic check of plan parameters was performed on

average in 1 min 45 sec. A typical result is shown in Figure

1. Average gamma pass-rate and γ

mean

over 380 fractions

was 99.5 (95% CI [97.1, 100]) and 0.38 (95% CI [0.33,0.44]),

respectively. All daily adapted plans passed criteria for

approval.

Verification of MC dose engine for site specific class-

solutions exhibited an excellent agreement with film

dosimetry, with average gamma pass-rate and γ

mean

of

100% of 0.14, respectively.

Conclusion

A patient specific QA procedure for online adaptive MR-

guided radiotherapy was successfully implemented at our

institution. This procedure, which takes less than 2

minutes, include online independent 3D MC dose

calculation after daily plan adaption and automatic check

of plan parameters while the patient is in treatment

position. A very good agreement with dose distribution

from the TPS was found for all adaptive fractions.

Proffered Papers: Variabilities in volume definition

OC-0263 Single vs. multi-atlas auto-segmentation for

prostate RT: Comparison of two commercial systems

A. Gulyban

1

, P. Berkovic

1

, F. Lakosi

2

, J. Hermesse

1

, P.A.

Coucke

1

, V. Baart

1

, D. Dechambre

1

1

Liege University hospital, Department of Radiation

Oncology, Liege, Belgium

2

Health Science Center- University of Kaposvar,

Radiation Oncology, Kaposvar, Hungary

Purpose or Objective

Using atlas-based auto-segmentation during treatment

planning has the potential to reduce the workload of the

staff while improving delineation consistency. Our aim was

to evaluate two commercial systems for prostate

treatment planning: evaluating volumetric accuracy 1)

while completing the atlas (learning curve), 2) using the

full atlas (performance) and 3) determining dose volume

histogram parameter (DVH) variations between of the

auto-generated and reference contours.

Material and Methods

Forty random prostate patient cases were selected for this

study. Each dataset consisted of a CT, a structure set

(including prostate, rectum, bladder, anal canal and

penile bulb) and the original dose matrix. Two systems

were used, the single-atlas based Raystation ('RS”,version

5.0.2, Stockholm, Sweden) and the multi-atlas based RTx

('MIR”, version 1.6.3, Mirada Medical, Oxford, UK). The 1-

5

th

case was used as base atlas. The learning phase was

completed in an incremental way, where each new auto-

contours generated using an atlas consisting of all former

cases (6

th

case used the atlas of 1-5

th

, 7

th

the 1-6

th

etc.)

until the 20

th

case. Performance was evaluated using the

complete (1-20

th

) atlas on another 20 cases (21-40

th

).

Analysis included the Dice Similarity Coefficient (DSC),

Jaccard index (JI), commonly contoured volumes (CCV),

volumetric ratios (VR) and 95% of the Hausdorff distance

(HD95%). Furthermore using the dose matrix, DVHs were

generated for all volumes and the differences of relevant

organs at risk specific parameters were compared. Mean

values and standard deviations (SD) were used for the

descriptive statistics and paired t-test to compare the MIR

vs. RS performance, while the Root mean squares (RMS)

were compared for the dosimetrical differences.

Results

For volumetric comparison (DSC, JI, and CCV, VR, HD95%)

21 vs. 14 out of 24 parameters improved from the learning

to the performance stages for MIR vs. RS respectively

(table 1). For rectum, MIR underestimated the volume (VR

for MIR 0.75 vs. RS 0.79, p<0.001), while for all other

parameters outperformed RS (p<0.001). Results for

bladder and prostate showed superior performance of MIR

with the exception of bladder CCV, which was not

significantly better compared to RS. Anal canal and penile

bulb showed poor agreement (for both systems). RS was

more accurate to estimate the anal canal volume; similar

results were obtained for penile bulb’s CCV, while all

other parameters were significantly better with MIR. RMS

values of MIR vs. RS resulting in 10.1 vs. 11.9 cc of V50Gy

and 4.7 vs. 8.0 Gy of mean dose for rectum, for bladder

V55Gy 22.4 vs. 27.3 cc and mean dose 8.6 vs. 8.6 Gy, while

for anal canal V20Gy of 6.9 vs. 6.3 cc and mean dose of

9.1

vs.

12.5

Gy

respectively.

Conclusion